These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 31196146)
1. Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation. Da Costa EM; Armaos G; McInnes G; Beaudry A; Moquin-Beaudry G; Bertrand-Lehouillier V; Caron M; Richer C; St-Onge P; Johnson JR; Krogan N; Sai Y; Downey M; Rafei M; Boileau M; Eppert K; Flores-Díaz E; Haman A; Hoang T; Sinnett D; Beauséjour C; McGraw S; Raynal NJ J Exp Clin Cancer Res; 2019 Jun; 38(1):251. PubMed ID: 31196146 [TBL] [Abstract][Full Text] [Related]
2. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells. Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Myc-induced histone modifications on target chromatin. Martinato F; Cesaroni M; Amati B; Guccione E PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155 [TBL] [Abstract][Full Text] [Related]
4. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Lee ER; Murdoch FE; Fritsch MK Stem Cells; 2007 Sep; 25(9):2191-9. PubMed ID: 17525233 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896 [TBL] [Abstract][Full Text] [Related]
6. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3. Vincek AS; Patel J; Jaganathan A; Green A; Pierre-Louis V; Arora V; Rehmann J; Mezei M; Zhou MM; Ohlmeyer M; Mujtaba S Molecules; 2018 Aug; 23(8):. PubMed ID: 30072621 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Santini V; Gozzini A; Ferrari G Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226 [TBL] [Abstract][Full Text] [Related]
8. Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. Frye M; Fisher AG; Watt FM PLoS One; 2007 Aug; 2(8):e763. PubMed ID: 17712411 [TBL] [Abstract][Full Text] [Related]
9. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Wiesel-Motiuk N; Assaraf YG Drug Resist Updat; 2020 Dec; 53():100729. PubMed ID: 33130515 [TBL] [Abstract][Full Text] [Related]
10. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia. Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821 [TBL] [Abstract][Full Text] [Related]
12. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment. Urdinguio RG; Lopez V; Bayón GF; Diaz de la Guardia R; Sierra MI; García-Toraño E; Perez RF; García MG; Carella A; Pruneda PC; Prieto C; Dmitrijeva M; Santamarina P; Belmonte T; Mangas C; Diaconu E; Ferrero C; Tejedor JR; Fernandez-Morera JL; Bravo C; Bueno C; Sanjuan-Pla A; Rodriguez RM; Suarez-Alvarez B; López-Larrea C; Bernal T; Colado E; Balbín M; García-Suarez O; Chiara MD; Sáenz-de-Santa-María I; Rodríguez F; Pando-Sandoval A; Rodrigo L; Santos L; Salas A; Vallejo-Díaz J; C Carrera A; Rico D; Hernández-López I; Vayá A; Ricart JM; Seto E; Sima-Teruel N; Vaquero A; Valledor L; Cañal MJ; Pisano D; Graña-Castro O; Thomas T; Voss AK; Menéndez P; Villar-Garea A; Deutzmann R; Fernandez AF; Fraga MF Nucleic Acids Res; 2019 Jun; 47(10):5016-5037. PubMed ID: 30923829 [TBL] [Abstract][Full Text] [Related]
13. Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells. Gupta J; Kumar S; Li J; Krishna Murthy Karuturi R; Tikoo K Biochimie; 2012 Dec; 94(12):2656-64. PubMed ID: 22951486 [TBL] [Abstract][Full Text] [Related]
14. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells. Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871 [TBL] [Abstract][Full Text] [Related]
15. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Wan L; Wen H; Li Y; Lyu J; Xi Y; Hoshii T; Joseph JK; Wang X; Loh YE; Erb MA; Souza AL; Bradner JE; Shen L; Li W; Li H; Allis CD; Armstrong SA; Shi X Nature; 2017 Mar; 543(7644):265-269. PubMed ID: 28241141 [TBL] [Abstract][Full Text] [Related]
16. Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage. Alam HB; Shults C; Ahuja N; Ayuste EC; Chen H; Koustova E; Sailhamer EA; Li Y; Liu B; de Moya M; Velmahos GC Resuscitation; 2008 Feb; 76(2):299-310. PubMed ID: 17822827 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Godino A; Jayanthi S; Cadet JL Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847 [TBL] [Abstract][Full Text] [Related]
18. CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells. Trisciuoglio D; Ragazzoni Y; Pelosi A; Desideri M; Carradori S; Gabellini C; Maresca G; Nescatelli R; Secci D; Bolasco A; Bizzarri B; Cavaliere C; D'Agnano I; Filetici P; Ricci-Vitiani L; Rizzo MG; Del Bufalo D Clin Cancer Res; 2012 Jan; 18(2):475-86. PubMed ID: 22068659 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid. Greve G; Schiffmann I; Lübbert M J Cancer Res Clin Oncol; 2015 Dec; 141(12):2171-80. PubMed ID: 26008188 [TBL] [Abstract][Full Text] [Related]